Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06522061

Evaluating the Effective and Safe Use of Stream™ Platform

The study aims to demonstrate the potential for at-home monitoring using Stream™ Platform, through simulated-use testing. Lay users, defined as subjects or nonprofessional caregivers, will be asked to operate Stream™ Platform. Safety, efficacy, and usability data will be collected to ensure that users are able to comply with prescribed device use.

Additionally, clinical testing will be conducted to identify correlations between measurements from Stream™ Platform and standard laboratory, radiological, and clinical assessments used for leak detection as part of the current standard of care (SOC) that may be skipped if the subject is discharged early.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

User-Centered Design Anastomotic Leak Artificial Intelligence Colorectal Surgery Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

St. Paul's Hospital - Providence Healthcare (PHC)

Vancouver, British Columbia, V6Z 1Y6, Canada

Location contact

Amandeep (Anu) Ghuman, BSc MD MPH FRCSC

SUB_INVESTIGATOR

Carl J Brown, BSc MSc MD FRCSC

CONTACT

[email protected]

604-682-2344

Carl J Brown, BSc MSc MD FRCSC

PRINCIPAL_INVESTIGATOR

Elizabeth Clement, BSc MSc MD FRCSC

CONTACT

[email protected]

Elizabeth Clement, BSc MSc MD FRCSC

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years - male or female.
  • Subject/SDM understands and has voluntarily signed and dated Informed Consent Form (ICF).
  • Subject underwent colorectal surgery with anastomosis.
  • Subjects must be willing to comply with trial requirements.
  • Subject has a prophylactic abdominal/pelvic drain after colorectal surgery.

Exclusion criteria

  • Subjects/caregiver is unwilling or unable to comply with the requirements of the protocol.
  • 24 hours or more have passed since the end of the subject's surgery and consent was not attained.
  • The subject had already developed an anastomotic leak at the time of screening and underwent surgery for treatment of the complication.
  • Plans that the subject will be discharged in less than 3 days post-surgery.
  • Subject has reported that they are pregnant.
  • Subject has a permanent end stoma.
  • Subject is delirious.
  • Subject has severe dementia.
  • Subject was involved in the planning and conduct of the clinical investigation.
  • Origin™ is not compatible with the drain used on the subject.
  • Subject and/or caregiver is/are not capable of conducting the calibrations for Stream™ Platform (this can be self-reported or determined by the CRC/HCP/other research staff).
  • The subject and/or caregiver is/are unable to understand the instructions provided for the management and calibration of Stream™ Platform (this can be self-reported or determined by the CRC/investigator/other research staff).

Treatment and study plan

Stream™ Platform

Device

Stream™ Platform consists of 5 main components: Origin™, Delta™ Monitor, Stream™ Application, Accessory Calibration Syringe(s), and Stream™ Cart. Origin™ is an inline biosensor system that can be attached between an off-the-shelf drainage catheter and evacuator bag/bulb system and is designed to monitor real-time changes in drained effluent characteristics (specifically pH and electrical conductivity (EC)) for the early identification of postoperative complications. Origin™ requires daily calibration (via Accessory Calibration Syringe(s)) for optimal performance and accuracy of its sensors. The Stream Application is a mobile application for displaying and analyzing data collected continuously via Origin™. Stream™ Application is pre-installed on Android mobile devices (called Delta™ Monitor) that are supplied by FluidAI. Origin connects to Stream Application via Bluetooth. Mobile carts/mounts, denoted Stream™ Carts/Delta Mounts, will be used to house the Delta™ Monitor.

Primary outcomes

  1. Evaluate if lay users can operate Stream Platform safely and effectively under healthcare providers supervision (simulated home use)

    Time frame: Through study completion, an average of 6-months

    • Statistical evaluation of the number of calibration errors encountered due to lay user error as reported by the healthcare providers.
    • Statistical evaluation of the number of calibration errors due to lay user errors that required intervention by the supervising healthcare provider to protect subject health and safety.
    • Occurrence of device associated adverse events including:

    i. Adverse Device Events (ADE) ii. Serious Adverse Device Events (SADE) iii. Unanticipated Serious Adverse Device Events (USADE) iv. Device Deficiencies

  2. Evaluate lay users' satisfaction through user feedback survey

    Time frame: Through study completion, an average of 6-months

    Subject reported overall satisfaction with daily calibrations and overall device.

    The following parameters will be recorded on a scale of 1-5:

    • System Related Feedback
    • Overall feedback on Stream Platform
    • Overall feedback on Stream Application
    • Training Related Feedback
    • Overall feedback on the instructions provided by Stream Application
    • Overall feedback on the training material provided including but not limited to training video, infographic, etc.
    • Overall feedback on the in-person training conducted
    • Subject Comfort Assessment
    • Overall subject experience performing ADLs (Activities of Daily Living) while Stream Platform is in use.
    • Overall subject experience sleeping while Stream Platform is in use

Secondary outcomes

  1. Utilize continuous pH and EC measurements collected prospectively using Stream™ Platform to supplement FluidAI's existing clinical model for early prediction of leakage after colorectal surgery.

    Time frame: Through study completion, an average of 6-months

    Data collected will be used to supplement Stream™ Platform's existing clinical model for early prediction of leakage.

  2. Identify correlations between measurements from Stream™ Platform and current standard of care (SOC).

    Time frame: Through study completion, an average of 6-months

    Assess if any strong correlations exist between pH/EC measurement collected using FluidAI's Stream™ Platform and other diagnostic biomarkers for AL

  3. Estimate the time taken by lay users to conduct calibration procedures

    Time frame: Through study completion, an average of 6-months

    Quantify the average time taken by subjects/caregiver to conduct calibration in seconds as measured by the Stream™ Platform

Study contacts

Contact information is provided by the study sponsor or research team.

Carl J Brown, BSc MSc MD FRCSC

CONTACT

[email protected]

604-682-2344

Sponsors and collaborators

Lead sponsor

FluidAI Medical

Industry

Registry information

Official study title

Evaluating the Effective and Safe Use of Stream™ Platform by a Lay User in a Simulated Environment

Acronym: Home-Stream

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 26, 2024
Registry last updated
Feb 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.